FindTrial
Sign In

Feasibility of ''Multimodal Sleep'' in the treatment of Chronic Intractable Insomnia

Feasibility and Biological Mechanism of ''Multimodal Sleep'' in the treatment of Chronic Intractable Insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035041
Enrollment
Unknown
Registered
2020-07-29
Start date
2015-03-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

patient-controlled sleep:dexmedetomidine

Sponsors

Aviation General Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged >=18 years old; 2. Participants fulfilled the diagnostic criteria for insomnia at least 3 months; 3. provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. serious somatic condition; 2. sleep apnea syndrome; 3. pregnant woman; 4. coagulation disorders; 5. working night shifts and unable or unwilling to discontinue this work pattern.

Design outcomes

Primary

MeasureTime frame
Blood pressure;heart rate;respiratory rate;peripheral arterial oxygen saturation;Pittsburgh Sleep Quality Index;Hamilton Depression Scale;Hamilton Anxiety Scale;—

Secondary

MeasureTime frame
Chinese versions of the Symptom Check list 90;—

Countries

China

Contacts

Public ContactJian-Xiong An

Aviation General Hospital of China Medical University

anjianxiong@yeah.net+86 13801281750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026